<DOC>
	<DOCNO>NCT00235521</DOCNO>
	<brief_summary>Inhaled nitrous oxide ( iNO ) compare aerosolize iloprost ( ILO ) pediatric patient cardiac surgery pulmonary hypertension . The hypothesis iloprost effective preventing pulmonary hypertensive crisis .</brief_summary>
	<brief_title>Iloprost-Study : Comparison Nitric Oxide Iloprost ( Ventavis ) Treatment Pulmonary Hypertension Children After Cardiopulmonary Bypass Surgery</brief_title>
	<detailed_description>Investigators , Study Sites : Single-center trial Department Pediatric Cardiology , Department Cardiac Surgery Department Anesthesiology , University Medical Center , Heidelberg , Germany Exploratory proof concept study ( Investigator initiate trial ) Indication : Postoperative pulmonary hypertension infant child undergo cardiopulmonary bypass surgery intracardiac repair left-to-right shunt Objectives : To compare efficacy aerosolize iloprost inhale nitric oxide prevent postoperative pulmonary hypertensive crisis Design : Exploratory , open label , randomize study parallel-group design ; Duration observation : 72 hour Population : Infants older 4 week child le 18 month age present left-to-right shunt increase pulmonary blood flow . Inclusion independent presence absence preoperative pulmonary hypertension Sample Size : - 20 patient : inhale nitric oxide ( iNO ) - group ; - 20 patient : aerosolize iloprost ( ILO ) -group Treatment : - Both group : control ventilation , sedation , analgetics , inotropic substance require , standardized intensive care treatment . - iNO - group : concentration iNO 10 ppm ; administer mechanical ventilation . - ILO - group : aerosolize Iloprost dose 0,5 µg/kg body weight ( 12x / 24h ) , administer ultrasound nebulizer . Efficacy Parameters : Occurrence `` minor '' `` major '' pulmonary hypertensive crisis ( PHTC ) Safety Parameters : Arterial blood pressure , oxygen saturation , complete blood count Statistical Procedures : All analyse exploratory trial descriptive , give confidence interval difference treatment group . Primary analysis variable : Rate occurrence `` major '' `` minor '' pulmonary hypertensive crisis Secondary variable : Presence hour pulmonary hypertension , Duration mechanical ventilation</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Informed consent parent legal representative Age : Infants older 4 week age child less 1½ year age . Presence lefttoright shunt increase pulmonary blood flow . The specific defect present : Aortopulmonary ( AP ) Window Atrioventricular septal defect ( AVSD ) Double outlet right ventricle ( DORV ) Total anomalous pulmonary venous drainage ( TAPVD ) Truncus arteriosus Ventricular septal defect ( VSD ) Presence postoperative PH immediately intracardiac repair : Patients enrol mean PAP intracardiac repair exceed 25 mmHg wean CPB . Specific cardiac defect : Atrial septal defect ( ASD ) Cyanotic congenital heart disease Univentricular atrioventricular connexion Valvular subvalvular pulmonary aortic stenosis Specific circumstance : Emergency cardiac surgery Children present infection cardiac surgery Infants extracorporeal membrane oxygenation ( ECMO ) cardiac surgery Infants/children treat epoprostenol Concomitant disease : Systemic arterial hypertension Renal failure Diabetes mellitus Known bleeding disorder ( know disorder blood coagulation hemostasis ) Infection first 24 hour cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Children</keyword>
	<keyword>Pediatric Patients</keyword>
	<keyword>Iloprost</keyword>
	<keyword>NO</keyword>
	<keyword>nitric oxide</keyword>
	<keyword>Pulmonary hypertension cardiac surgery pediatric patient , 0 - 2 year old</keyword>
</DOC>